Dr. Stephen Michael Schatz, MD

Dr. Schatz practices at WellSpan York Hospital in York, Pennsylvania, part of WellSpan Health.

Dr. Schatz's NPI, 1144289026, was assigned on March 21, 2006. Dr. Schatz graduated from University of Pittsburgh School of Medicine in 1999. Dr. Schatz holds Pennsylvania license MD475105.

Dr. Schatz's primary practice is WellSpan York Hospital, at 1001 South George Street, York, PA 17403 in York County. The practice phone is (717) 851-2345.

Dr. Schatz's primary practice is WellSpan York Hospital in York, Pennsylvania, part of WellSpan Health. Dr. Schatz is also affiliated with WellSpan Chambersburg Hospital. The medical group on file is WellSpan Digestive Health. Dmand AI also links Dr. Schatz to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schatz practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Schatz's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Schatz's licenses on file in 3 states: Pennsylvania, Maryland and Texas.

CMS data shows 6,222 Medicare services from Dr. Schatz across 27 procedure codes in 2024, for 594 Medicare patients. Medicare paid $143,707 for them.

CMS counts 594 Medicare patients who saw Dr. Schatz in 2024. The largest group is 65 to 74, with 265 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Schatz's median patient age at 73, with 25% women.

In 2024, Dr. Schatz wrote 1,539 Medicare Part D claims for 461 patients. 93% of them were for generic drugs. CMS names the drug for 1,383 of them, across 22 drugs with 11 or more claims each, at $89,428 in total drug cost. In 2023, CMS named 1,150 claims across 18 drugs.

Dr. Schatz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schatz as offering telehealth. CMS counts 15 procedures of prostate resection by Dr. Schatz, more than 72% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links Dr. Schatz to 1 clinical trial. Conditions studied include Urinary Retention and Prostatic Hyperplasia.

CMS Open Payments shows 66 general payments to Dr. Schatz from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. Boston Scientific Corporation paid the most, $438.

Dr. Schatz graduated from University of Pittsburgh School of Medicine in 1999.